Updates
This is to inform that due to unavoidable circumstances, the Company hereby withdraws the present QIP issue.19-01-2018
Updates
This is to inform that due to unavoidable circumstances, the Company hereby withdraws the present QIP issue.Updates
With reference to the QIP issue of Venus Remedies Limited , please be informed that company has informed to the QIBs regarding material development pertains to the declaration of the company and its directors as 'Wilful Defaulters' by the Export-Import Bank of India (EXIM). The company has given five days to the QIBs to take their decision on QIPBoard Meeting Postponed
This is to inform that board meeting scheduled to be held on 13.01.2018 is postponed till further notice.Shareholding for the Period Ended December 31, 2017
Venus Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click hereInvestor Grievance Report For The Quarter Ended On 31.12.2017
Pursuant to Listing Agreement and Regulation 13(3) of SEBI (LODR) Regulations 2015, we hereunder submit report of Investor grievance the quarter ended on 31.12.2017: Investor Complaint pending at the beginning of quarter : Nil Investor Complaint received during the quarter : Eight Investor Complaint disposed off during the quarter : Eight Investor Complaint pending at the end of quarter : NilBoard Meeting Dated 13.01.2018
This is to inform you that the meeting of Board of Directors is scheduled to be held on Saturday, 13th January 2018 to inter alia consider and approve: 1. To allot the shares to eligible Qualified Institutional Buyers under QIP issue. 2. To apply for listing approval with Stock Exchanges Further, pursuant to the provisions of Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, it has been...Outcome of Board Meeting
This is to inform you that, the Board of Directors of the Company at its meeting held today inter alia considered and approved as follow: 1. Approved and declared the Closing of QIP issue on.10th January 2018 2. Determined and approved the Issue price Rs103.6484 per Equity Shares rounded off to Rs.103.65 and the number of shares allocated to eligible Qualified Institutional Buyers under QIP. 3. Approved and adopted Placement Document dated 10th January 2018 for QIP.Board Meeting Dated 10.01.2018 For QIP
This is to inform you that the meeting of Board of Directors is scheduled to be held on Wednesday, 10th January 2018 to inter alia consider and approve: 1. To take note of Bids received from the QIB 2. To close the QIP issue. 3. To allocate the number of shares to the QIB 4. To decide the Issue price for QIP issue. 5. To approve Placement Document for QIP issue....Outcome of Board Meeting
This is to inform you that, the Board of Directors of the Company at its meeting held today inter alia considered and approved as follow: 1. Opening of QIP issue on 9th January 2018 2. Approval of draft Preliminary Placement Document dated 8th January 2018 for QIP. 3. Taken note of Floor price as calculated by ICDR guidelines....